Latest Stories
3 Reasons AIN is Risky and 1 Stock to Buy Instead
Albany’s stock price has taken a beating over the past six months, shedding 25.3% of its value and falling to $50.29 per share. This was partly driven by its softer quarterly results and might have investors contemplating their next move.
3 Reasons to Sell OZK and 1 Stock to Buy Instead
Although Bank OZK (currently trading at $48.25 per share) has gained 7.4% over the last six months, it has trailed the S&P 500’s 13.6% return during that period. This was partly due to its softer quarterly results and might have investors contemplating their next move.
3 Reasons to Sell MCFT and 1 Stock to Buy Instead
Even though MasterCraft (currently trading at $19.07 per share) has gained 6.3% over the last six months, it has lagged the S&P 500’s 13.6% return during that period. This might have investors contemplating their next move.
3 Reasons to Avoid LZB and 1 Stock to Buy Instead
La-Z-Boy currently trades at $39.49 per share and has shown little upside over the past six months, posting a middling return of 3.1%. The stock also fell short of the S&P 500’s 13.6% gain during that period.
3 Reasons BOOT is Risky and 1 Stock to Buy Instead
Boot Barn currently trades at $195.13 and has been a dream stock for shareholders. It’s returned 377% since December 2020, blowing past the S&P 500’s 83.9% gain. The company has also beaten the index over the past six months as its stock price is up 19.5% thanks to its solid quarterly results.
3 Reasons FHN is Risky and 1 Stock to Buy Instead
First Horizon’s 22.7% return over the past six months has outpaced the S&P 500 by 9%, and its stock price has climbed to $23.93 per share. This was partly thanks to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
Lumen (LUMN): Buy, Sell, or Hold Post Q3 Earnings?
What a time it’s been for Lumen. In the past six months alone, the company’s stock price has increased by a massive 91.9%, reaching $7.64 per share. This was partly due to its solid quarterly results, and the performance may have investors wondering how to approach the situation.
3 Reasons ARES Has Explosive Upside Potential
Since June 2025, Ares has been in a holding pattern, posting a small return of 1.7% while floating around $170.19. The stock also fell short of the S&P 500’s 13.6% gain during that period.
3 Reasons to Avoid STKL and 1 Stock to Buy Instead
SunOpta has gotten torched over the last six months - since June 2025, its stock price has dropped 35.4% to $3.82 per share. This might have investors contemplating their next move.
Winners And Losers Of Q3: Edgewell Personal Care (NYSE:EPC) Vs The Rest Of The Personal Care Stocks
Looking back on personal care stocks’ Q3 earnings, we examine this quarter’s best and worst performers, including Edgewell Personal Care (NYSE:EPC) and its peers.